July 30, 2024Open Access

Polymyxin B Plus Aerosolized Colistin vs Polymyxin B Alone in Hospital-acquired Pneumonia (“AEROCOL” Study): A Feasibility Study

Key Points

Key points are not available for this paper at this time.

Abstract

In hospital-acquired pneumonia (HAP) due to extensively drug resistant gram-negative pathogens, can treatment with high-dose colistin aerosolization using specific aerosol delivery protocol, improve clinical outcome in addition to systemic polymyxin-B?

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Supradip Ghosh (Tue,) studied this question.

synapsesocial.com/papers/68e5e6efb6db64358757bb9d — DOI: https://doi.org/10.5005/jp-journals-10071-24767

Authors

Supradip Ghosh

Max Super Speciality Hospital

Journals

Indian Journal of Critical Care Medicine

Actions

Institutions

Fortis Escorts Hospital

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Polymyxin B Plus Aerosolized Colistin vs Polymyxin B Alone in Hospital-acquired Pneumonia (“AEROCOL” Study): A Feasibility Study

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion